These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 15208676
1. ERbeta exerts multiple stimulative effects on human breast carcinoma cells. Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Liu G, Lu LJ, Shen ZZ, Ding J, Shao ZM. Oncogene; 2004 Jul 29; 23(34):5799-806. PubMed ID: 15208676 [Abstract] [Full Text] [Related]
2. [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line]. Hou YF, Yuan ST, Li HC, Wu J, Lu JS, Lu LJ, Liu G, Shen ZZ, Ding J, Shao ZM. Zhonghua Zhong Liu Za Zhi; 2005 Jul 29; 27(7):389-92. PubMed ID: 16188119 [Abstract] [Full Text] [Related]
5. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex. Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC. Int J Oncol; 2005 Aug 29; 27(2):327-35. PubMed ID: 16010412 [Abstract] [Full Text] [Related]
6. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness. Foos G, Hauser CA. Oncogene; 2000 Nov 16; 19(48):5507-16. PubMed ID: 11114728 [Abstract] [Full Text] [Related]
11. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Li DQ, Hou YF, Wu J, Chen Y, Lu JS, Di GH, Ou ZL, Shen ZZ, Ding J, Shao ZM. Eur J Cancer; 2006 Dec 16; 42(18):3274-86. PubMed ID: 16979889 [Abstract] [Full Text] [Related]
13. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH. Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518 [Abstract] [Full Text] [Related]
14. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM. J Steroid Biochem Mol Biol; 2005 Feb 04; 94(1-3):71-81. PubMed ID: 15862952 [Abstract] [Full Text] [Related]
15. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor]. Lin Y, Wang SM, Huang RP. Zhonghua Yi Xue Za Zhi; 2005 Jun 01; 85(20):1419-23. PubMed ID: 16029657 [Abstract] [Full Text] [Related]
18. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H, Mansel RE, Jiang WG. Int J Oncol; 2005 May 01; 26(5):1429-34. PubMed ID: 15809737 [Abstract] [Full Text] [Related]
19. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk. Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH. Mol Cancer Res; 2004 Sep 01; 2(9):523-31. PubMed ID: 15383631 [Abstract] [Full Text] [Related]